You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The researchers noted that 93 of the newly identified loci are found in both African-American and European populations, and only 18 are European-specific.
The team's assembly represents 95 percent of the genomic sequence of barley, the most complete version of that genome to date.
An Australian team has sequenced and mapped the genome of a prostate cancer tumor, as the Australian Financial Review reports.
At AGBT, an early adopter of Bionano's technology discussed how his lab is using it in conjunction with NGS to diagnose rare diseases.
The company's Irys genome mapping technology provides researchers with a non-sequencing-based tool that is essential for studying structural variation.
The public-private consortium, led by the National Institute of Standards and Technology, recently released four new reference materials.
At a workshop organized by the Genome in a Bottle consortium last month, Nabsys presented its human genome maps for the first time.
BioNano plans to develop structural variant assays on its Irys system for diagnostic use in China as a first step in bringing its technology to the clinic.
BGI has signed an agreement to offer NRGene's bioinformatics tools as part of its agricultural genomic analysis service to customers in Asia.
Researchers at the Joint Genome Institute and elsewhere have been working on understanding the genomes of switchgrass and a close relative in order to use the plants to make better biofuels.
According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.
A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.
In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.
The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.